NHS-Doxorubicin
N-hydroxylsuccinimide-Doxorubicin
Product description
N-hydroxylsuccinimide-Doxorubicin NHS-Doxorubicin from ruixi N-hydroxylsuccinimide-Doxorubicin ,NHS-Doxorubicin,Doxorubicin-NHS from ruixi.Doxil is a version of the chemotherapy medication doxorubicin that is covered in a protective coating, which allows it to avoid destruction by the bodys immune system and remain in the body for a longer amount of time. As a result, Doxil has more time to reach the tumor tissue, where the medication is then slowly released. Doxorubicin liposomal interferes with the growth of cancer cells and slows their spread in the body by inhibiting DNA synthesis and causing the production of harmful free radicals.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| Solubility | Organic solvents |
| Purity | >95% |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 years |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of NHS-Doxorubicin
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


